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Kellgren–Lawrence gradingAbstract Aim of the work: The purpose of this study was to evaluate the relationship of serum
leptin level and osteoporosis in postmenopausal women with knee osteoarthritis (KOA).
Patients and methods: The study included 40 postmenopausal women with primary KOA and 37
age-matched postmenopausal healthy controls. Plain X-ray knees were performed and assessed
using the Kellgren–Lawrence (KL) grading scale. Bone mineral density (BMD) was assessed using
dual-energy X-ray absorptiometry (DXA) in lumbar spine, hip and forearm regions. As a bone
turn-over marker serum osteocalcin was measured. Serum leptin level was assessed in patients
and control.
Results: The mean age of the KOA patients was 58.05 ± 5.7 years. Osteoporosis was detected
among 15% of the KOA patients and 35.1% of the control. The BMD was significantly increased
at the spine and wrist in the patients than in the control (p= 0.011 and p= 0.015 respectively). The
serum osteocalcin was comparable between patients (19.74 ± 8.05 ng/ml) and control (21.2
± 8.36 ng/ml) (p= 0.5). Serum leptin was significantly higher in the patient (58.7 ± 27.17 ng/
ml) compared to the control (48.75 ± 13.19 ng/ml) (p= 0.048), and significantly correlated with
the degree of KOA (p= 0.017). No significant correlation was found between serum osteocalcin
level or the BMD and the degree of KOA. There was a significant negative correlation between
serum osteocalcin level and forearm BMD in KOA patients (r= 0.33, p= 0.038).
Conclusions: Although postmenopausal women with KOA had significantly higher BMD, both
diseases can coexist. It seemed that osteoarthritis does not prevent the occurrence of osteoporosis.
Our study suggested a promising role of leptin as a biomarker of KOA.
 2016 Egyptian Society of Rheumatic Diseases. Publishing services provided by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Osteoarthritis (OA) and osteoporosis (OP) are extremely fre-
quent among elderly people and their impact on life quality
makes them of high socio health relevance. While OA is a joint
disease characterized by degeneration of articular cartilage and
bone remodeling that may affect different sites and involve
peripheral or axial joints [1], OP is characterized by low bone
mass, and microarchitectural deterioration of bony tissue, with
a consequent increase in bone fragility and susceptibility to
fractures. According to the WHO criteria, osteoporosis can
also be defined as a value of bone mineral density (BMD) more
than 2.5 standard deviations below the young normal mean [2].
It would be anticipated that osteoporosis and osteoarthritis
frequently coexist due to their high prevalence in elderly
women but the association between these conditions is still
controversial [3,4] even after years of research since the first
results indicate an apparent inverse relationship [5,6]. Indeed,
many studies have shown an association between high bone
mineral density at the spine and hip and OA of the hips, knees
or hands [7–10]. However, other studies failed to show an
inverse relationship between OA and OP and reported
impaired bone quality and increased risk of fracture in patients
with OA [11–14].
Leptin is a protein hormone that plays a key role in regulat-
ing energy intake and expenditure [15]. High leptin levels were
associated with obesity, which is a risk factor for OA [16].
Findings on effects of leptin on bone metabolism are partly
contradictory. There are studies where a positive association
has been found between leptin and BMD [17,18], while there
are also studies reporting no significant association [19,20] or
a negative association [21,22].
We undertook this study to determine the association
between radiographic features of knee osteoarthritis (KOA),
and BMD at different measured sites, as well as to investigate
the underlying mechanism at the tissue level through assess-
ment of osteocalcin as a biochemical marker of bone turnover.
We also evaluated the relationship of serum leptin level, osteo-
porosis and KOA in postmenopausal women.
2. Patients and methods
The study involved 40 postmenopausal women with KOA
according to ACR clinical classification criteria forTable 1 Demographic features, bone mineral density, serum l
osteoarthritis and in control.
Characteristics mean ± SD or median (range) Pos
KO
Age (years) 58.0
Age of menopause (years) 51(4
BMI 36.0
BMD Lumbar spine 1.13
Femoral neck 0.99
Forearm 0.71
Serum leptin level (ng/ml) 58.7
Serum osteocalcin level (ng/ml) 19.7
KOA: knee osteoarthritis, BMD: bone mineral density, BMI: body mass
* Significant at p < 0.05.osteoarthritis of the knee and 37 age-matched postmenopausal
women asymptomatic for KOA were included as a control
group.
The study was explained to the participants and an
informed consent was given by each, after approval from the
local ethics committee of the Faculty of Medicine, Alexandria
University. The exclusion criteria were (1) clinical and radio-
logical signs of secondary OA such as, post traumatic, meta-
bolic, and other rheumatological diseases. (2) Using drugs
known to influence bone metabolism in the past two years,
such as corticosteroids, bisphosphonates, sodium fluoride,
raloxifene, strontium ranelate, teriparatide and hormone
replacement therapy. (3) Thyroid, parathyroid, adrenal, hep-
atic, or renal disease; (4) malignancy; (5) hysterectomy; (6)
smoking; and (7) alcohol intake.
Each participant completed a questionnaire on demo-
graphic parameters and personal history such as age of meno-
pause, coffee intake, calcium and vitamin D supplement, and
history of fragility fracture. The body mass index (BMI) was
calculated. Plain X-ray knees (antero-posterior and lateral
views) were performed while standing. The radiographs were
subsequently evaluated by a single observer. The disease sever-
ity was assessed using the Kellgren–Lawrence (KL) grading
scale [23]. Radiological KOA was defined as Pgrade 2 on
KLG scale.
Lumbar spine, femoral neck and forearm bone mineral den-
sity (BMD) were measured by dual-energy X-ray absorptiom-
etry (DXA) with a lunar prodigy densitometer. T score was
obtained.
Morning fasting blood was collected from every subject for
the measurement of serum osteocalcin (OCN) level. Electro
chemiluminescence immunoassay of N-MID OCN was done
using Elecsys 2010 immunoassay analyzer. Serum leptin con-
centrations were determined in all participants using an
enzyme linked immunosorbent assay (ELISA) technique.
Statistical analysis: Data were analyzed using IBM SPSS
software package version 20.0. Descriptive data were expressed
as mean and standard deviation. Univariate analyses including
t-test and Mann–Whitney test were used to test the significance
of the results of quantitative variables. Moreover, Fisher’s
exact test was used to test for significance among qualitative
variables. Linear correlations were conducted to show the rela-
tionship between BMD of the lumbar spine, hip and forearm,
OA severity and other studied parameters. The significance of
the results was at the 5% level of significance.eptin and osteocalcin in postmenopausal patients with knee
tmenopausal women (n= 77)
A patient (n= 40) Control (n= 37) p value
5 ± 5.7 57.27 ± 5.6 0.55
5–55) 50 (42–56) 0.21
3 ± 5.9 33.7 ± 4.9 0.07
± 0.17 1.03 ± 0.16 0.01*
± 0.13 0.94 ± 0.14 0.053
± 0.08 0.65 ± 0.07 0.018*
± 27.17 48.75 ± 13.19 0.048*
4 ± 8.05 21.2 ± 8.36 0.5
index.
Table 2 Bone mineral density among the postmenopausal
women with and without knee osteoarthritis.






Spine Normal 23 (57.5) 15 (40.5) 0.011*
Osteopenia 14 (35) 9 (24.3)
Osteoporosis 3 (7.5) 13 (35)
Hip Normal 25 (62.5) 21 (56.7) 0.3
Osteopenia 15 (37.5) 14 (37.8)
Osteoporosis 0 (0) 2 (5.4)
Forearm Normal 28 (70) 14 (37.8) 0.015*
Osteopenia 10 (25) 17 (46)
Osteoporosis 2 (5) 6 (16.2)
Overall Normal 19 (47.5) 9 (24.2) 0.035*
Osteopenia 15 (37.5) 15 (40.5)
Osteoporosis 6 (15) 13 (35.3)
BMD: Bone mineral density, KOA: knee osteoarthritis.
* Significantly different at p< 0.05.
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Characteristics of participants enrolled in this study are shown
in Table 1. The age, age of menopause, and BMI were compa-
rable between patients and controls. Patients had significantly
higher BMD in the lumbar spine and forearm regions com-
pared to the control. Serum leptin level was significantly higher
in the patients than in the control, while serum osteocalcin
level was comparable.
Regarding the KL grading scale, in the KOA patients 7
(17.5%) were grade 2, 23 (57.5%) grade 3 and 10 (25%) were
grade 4; while in the control 11 (29.7%) were grade 2 and 26
(70.3%) grade 1. Plain xray knee of a KOA patient is pre-
sented in Fig. 1.
Regarding the BMD, in the patients 47.5% were normal,
37.5% osteopenic and 15% were osteoporotic, while in the
control group 24.2% were normal, 40.5% osteopenic and
35.3% were osteoporotic (Table 2). The DXA of a KOA
patient with normal BMD and a control with osteoporosis
of the spine and osteopenia of the hip and forearm are shown
in Figs. 2 and 3.
There was a significant correlation between KL grading and
serum leptin level in KOA patients only. KL grading did not
correlate with other parameters (Table 3). There was a signif-
icant negative correlation between serum osteocalcin level and
forearm BMD in KOA patients (r= 0.33, p= 0.038) but
not with the lumbar spine and hip regions. Serum leptin level
did not significantly correlate with the BMD or serum osteo-
calcin level in both groups.
4. Discussion
Our data showed that postmenopausal women with KOA had
significantly higher BMD of lumbar spine and forearm regions
compared to the control. This was in agreement with the
results of other studies [24–26]. However, 15% of the KOA
patients were osteoporotic. Thus, although an apparent inverseFigure 1 Right knee plain X-ray (anteroposterior view) for a
postmenopausal knee osteoarthritis (KOA) patient with KL grade
3 showing narrowing of joint space, moderate multiple osteo-
phytes, some sclerosis, and deformity of bone contour.relationship between KOA and osteoporosis can be detected,
KOA did not appear to be protective against osteoporosis.
Moreover, no significant relationship was detected between
the KL grade of KOA and BMD in both groups. Results of
the current study were consistent with the findings of other
studies [27–29]. Other studies showed contradictory results
[25,30,31] where BMD was significantly related to the severity
of KOA.
The current work and all previously mentioned studies were
cross-sectional and did not demonstrate the influence of BMD
change on the progression of KOA. Other studies have inves-
tigated the longitudinal association between BMD and KOA.
The study by Bergink et al. [32] observed that high BMD at
baseline was associated with increased incidence and progres-
sion of KOA. Zhang et al. [33] demonstrated an increased inci-
dence of KOA with increasing BMD, mainly via increased
osteophytes whereas; high BMD gain was shown to decrease
the risk of radiographic progression. The association between
KOA and BMD was denied in the studies conducted by Hart
et al. [34], and Nevitt et al. [35]. On the other hand, Ding et al.
[36] demonstrated higher rates of total hip bone loss among
subjects with radiographic progressive hip and knee OA. This
observation was further supported by Lee et al. [37] where
knee MRI was done at baseline, year 1 and year 2 follow-up.
Longitudinal BMD loss was associated with cartilage loss in
KOA. Thus, osteoporosis did not prove to be protective
against progression of knee OA.
In the current study, there was no significant difference
between patients and control regarding the mean serum level
of osteocalcin. This was in harmony with the studies con-
ducted by Jaing et al. [38] and Stewart et al. [39]. On the con-
trary, it has been found that in patients with advanced KOA
the serum and synovial osteocalcin levels were lower than in
the control [40] and in another study a significant elevation
of osteocalcin was present in KOA patients relative to age
and sex matched controls [41].
Osteocalcin level did not significantly correlate with KL
grading scale of KOA in patients and controls. The results
were consistent with the study conducted by Naitou et al.
[42]. In contrast, Bruyere et al. [43] found that increased serum
Figure 2 The DXA of a 63 year old postmenopausal patient with KL grade 4 knee osteoarthritis (KOA) showing normal bone mineral
density (BMD).
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Such discrepancies suggest that osteocalcin may have limited
utility as an OA biomarker.
The mean serum leptin level was significantly higher in the
patients than the control (p= 0.04). This finding was consis-
tent with the study conducted by Boer et al. [44] where the adi-
pokine levels particulary adiponectin and leptin were distinctly
higher in severe KOA patients and significantly correlated with
KL grading. These findings highlighted the role of leptin as a
mediator of the immuno-inflammatory response in KOA.
The BMI was comparable in the present study between
patients and control. In another study on obese Egyptian
patients with KOA from Alexandria, leptin was found to play
a key role and significantly correlated with knee pain, func-tional impairment, inflammatory cytokines and cartilage
degradation [45]. Furthermore, it has been suggested that a
deeper understanding of the effects of biochemical parameters
on the initiation and progression of KOA will help
finding future therapeutic targets to prevent and treat the
disease [46].
Our study has certain limitations; (1) cross-sectional design,
as it did not examine the causal relationship between
osteoarthritis and osteoporosis. (2) Using a semiquantitative
(subjective) score to classify the radiographic features of
KOA is subject to errors of interpretation. (3) About 30% of
the asymptomatic women in the control had radiological evi-
dences of mild KOA (4) BMD measurement at the spine is
subject to artifacts such as osteophytes, endplate sclerosis,
Figure 3 The DXA of a 56 year old postmenopausal control with KL grade 2 showing osteoporosis at the lumbar spine, and osteopenia
at the left hip and forearm.
Table 3 Correlation of Kellgren Lawrence grading with
serum osteocalcin, serum leptin and bone mineral density in
postmenopausal women with and without knee osteoarthritis.
r (p) KL grading
KOA patients (n= 40) Control (n= 37)
Serum osteocalcin 0.22 (0.2) 0.18 (0.28)
Serum leptin 0.38 (0.017)* 0.23 (0.17)
BMD
Spine 0.22 (0.38) 0.14 (0.41)
Hip 0.2 (0.22) 0.10 (0.55)
Forearm 0.002 (0.99) 0.03 (0.19)
KL: Kellgren Lawrence, BMD: bone mineral density.
* Significantly different at p< 0.05.
Serum leptin and osteoporosis in postmenopausal women 213fatty degeneration, and vascular calcifications that can elevate
the apparent BMD and mask age- or diseased-related bone
loss.
In conclusion, this study showed that although post meno-
pausal women with knee OA have higher BMD compared to
the control, KOA did not seem to be protective against the
development of osteoporosis. Actually, both diseases can coex-
ist in the same patient. This highlighted the point that patients
with OA should not be overlooked when screening of post-
menopausal women is carried out to detect osteoporosis.
Serum leptin has proved to be a promising biomarker of
KOA, while osteocalcin may have limited utility as an OA
biomarker.
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